Genipin-1-β-D-gentiobioside efficiently suppressed inflammation and oxidative stress, thus improving renal function in a model of diabetic nephropathy, partly via AMPK/SIRT1 activation and NF-κB inhibition. Here, NFKB1 is linked to diabetic kidney disease.